How does methadone differ from morphine in NMDA receptor activity and its clinical implications?

• A. Morphine blocks NMDA receptors; methadone does not.
• B. Methadone blocks NMDA receptors contributing to analgesia and neuropathic pain relief; morphine does not.
• C. Both methadone and morphine block NMDA receptors equally.
• D. Neither methadone nor morphine affects NMDA receptors.

Answer: (B)

NMDA receptors play a role in central sensitization and neuropathic pain, so drugs that block these receptors can reduce wind-up and enhance analgesia in certain chronic pain states. Methadone is unique among common opioids because it both activates mu-opioid receptors and acts as an NMDA receptor antagonist at clinically relevant doses. This NMDA antagonism adds a non-opioid mechanism that helps with neuropathic pain and can help mitigate central sensitization, potentially slowing the development of opioid tolerance and hyperalgesia with long-term use. Morphine, on the other hand, provides analgesia mainly through mu-opioid receptor activation and has little meaningful NMDA receptor antagonism. Thus, methadone’s NMDA receptor blockade contributing to analgesia and neuropathic-pain relief, in contrast to morphine, best explains the difference in their pharmacology and clinical implications.